NORD’s Dr. Neilan Discusses Next Steps for Rare Disease Clinical Trials
XTalks
DECEMBER 22, 2022
NORD, along with its more than 330 member patient organizations, is “committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services.”. Can you tell us a bit about the work you are doing at NORD and how it impacts clinical trials for rare diseases?
Let's personalize your content